Inicio › Cáncer de seno › Nuevo México › Albuquerque
Ensayos clínicos de Cáncer de seno en Albuquerque, NM
17 estudios para Cáncer de seno buscan participantes en centros de Albuquerque y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
ReclutandoFase 3
- Presbyterian Medical Group, Albuquerque
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Lovelace Medical Center-Saint Joseph Square, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
- Lovelace Women's Hospital, Albuquerque
- y 1 más
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
ReclutandoFase 2
- The University of New Mexico, Albuquerque
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
ReclutandoFase 3
- Presbyterian Kaseman Hospital ( Site 0072), Albuquerque
- University of New Mexico Comprehensive Cancer Center ( Site 0047), Albuquerque
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
ReclutandoFase 3
- Research Site, Albuquerque
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
ReclutandoFase 3
- Lovelace Medical Center - Saint Joseph Square, Albuquerque
- Lovelace Women's Hospital, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
- y 1 más
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Reclutando
- New Mexico Oncology & Hematology Consultants, Albuquerque
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ReclutandoFase 3
- Exigent Research LLC/New Mexico Oncology Hematology Consultants Ltd., Albuquerque
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
ReclutandoFase 1/2
- Research Site, Albuquerque
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ReclutandoFase 3
- University of New Mexico Cancer Center, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
ReclutandoFase 3
- Presbyterian Kaseman Hospital, Albuquerque
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
ReclutandoFase 3
- University of New Mexico Cancer Center, Albuquerque
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Reclutando
- University of New Mexico, Albuquerque
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Lovelace Medical Center-Saint Joseph Square, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
- Lovelace Women's Hospital, Albuquerque
- y 1 más
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Albuquerque
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
ReclutandoFase 3
- University of New Mexico Cancer Center, Albuquerque
BostonGene and Exigent Genomic INsight Study
ReclutandoEstudio observacional
- New Mexico Cancer Center, Albuquerque
Más información sobre Cáncer de seno en MedlinePlus
Ensayos de Cáncer de seno en otras ciudades
- New York City, NY136 estudios
- Houston, TX126 estudios
- Boston, MA112 estudios
- Nashville, TN81 estudios
- Los Angeles, CA73 estudios
- Edison, NJ68 estudios
- St. Louis, MO64 estudios
- Queens, NY64 estudios
- Durham, NC64 estudios
- Chicago, IL59 estudios
- Philadelphia, PA56 estudios
- Dallas, TX55 estudios
Otros estudios en Albuquerque
- Cáncer de pulmón de células no pequeñas18 estudios
- Cáncer de ovario15 estudios
- Cáncer (todos los tipos)14 estudios
- Cáncer de pulmón14 estudios
- Cáncer metastásico12 estudios
- Cáncer de endometrio12 estudios
- Diabetes tipo 211 estudios
- Enfermedad cardiovascular10 estudios
- Melanoma9 estudios
- Leucemia mielógena aguda9 estudios
- Cáncer de próstata9 estudios
- Enfermedad renal crónica8 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.